Juergen Prattes

4.2k total citations · 1 hit paper
79 papers, 2.3k citations indexed

About

Juergen Prattes is a scholar working on Infectious Diseases, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Juergen Prattes has authored 79 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Infectious Diseases, 62 papers in Epidemiology and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Juergen Prattes's work include Antifungal resistance and susceptibility (61 papers), Fungal Infections and Studies (46 papers) and Pneumocystis jirovecii pneumonia detection and treatment (12 papers). Juergen Prattes is often cited by papers focused on Antifungal resistance and susceptibility (61 papers), Fungal Infections and Studies (46 papers) and Pneumocystis jirovecii pneumonia detection and treatment (12 papers). Juergen Prattes collaborates with scholars based in Austria, United States and Germany. Juergen Prattes's co-authors include Martin Hoenigl, Robert Krause, Susanne Eigl, Reinhard B. Raggam, Jeffrey D. Jenks, Dieter Buchheidt, Albert Wölfler, Christopher R. Thornton, Ines Zollner‐Schwetz and Matthias Egger and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Juergen Prattes

73 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Antifungal Pipeline: Fosmanogepix, Ibrexafungerp, Olorofim, Opelconazole, and Rezafungin

2021 283 citations Martin Hoenigl, Rosanne Sprute et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Juergen Prattes Austria	29	2.0k	1.7k	284	265	237	79	2.3k
Philipp Koehler Germany	21	1.7k 0.8×	1.2k 0.7×	220 0.8×	123 0.5×	132 0.6×	61	2.0k
Charalampos Antachopoulos Greece	28	1.3k 0.6×	1.3k 0.7×	152 0.5×	243 0.9×	189 0.8×	79	2.4k
Y. J. Debets-Ossenkopp Netherlands	23	1.4k 0.7×	1.1k 0.7×	246 0.9×	474 1.8×	279 1.2×	38	2.4k
Н Н Климко Russia	18	1.8k 0.9×	1.4k 0.8×	119 0.4×	191 0.7×	155 0.7×	94	2.0k
Chris Kosmidis United Kingdom	25	1.2k 0.6×	1.1k 0.6×	424 1.5×	243 0.9×	98 0.4×	77	2.3k
R.A. Barnes United Kingdom	17	1.3k 0.7×	1.1k 0.6×	169 0.6×	135 0.5×	130 0.5×	26	1.6k
Takahiro Takazono Japan	20	1.1k 0.5×	1.0k 0.6×	278 1.0×	179 0.7×	90 0.4×	166	1.6k
Laura Kovanda United States	27	2.5k 1.2×	2.0k 1.2×	297 1.0×	299 1.1×	78 0.3×	57	2.8k
Anna Skiada Greece	24	3.5k 1.7×	2.7k 1.6×	160 0.6×	361 1.4×	167 0.7×	36	4.1k
B. Lebeau France	23	1.5k 0.8×	1.1k 0.6×	145 0.5×	158 0.6×	316 1.3×	56	1.9k

Countries citing papers authored by Juergen Prattes

Since Specialization

Citations

This map shows the geographic impact of Juergen Prattes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juergen Prattes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juergen Prattes more than expected).

Fields of papers citing papers by Juergen Prattes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juergen Prattes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juergen Prattes. The network helps show where Juergen Prattes may publish in the future.

Co-authorship network of co-authors of Juergen Prattes

This figure shows the co-authorship network connecting the top 25 collaborators of Juergen Prattes. A scholar is included among the top collaborators of Juergen Prattes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juergen Prattes. Juergen Prattes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bethe, Ullrich, Peter Borchmann, Veronica Di Cristanziano, et al.. (2025). Immunogenicity of COVID-19 Vaccination in Immunocompromised Patients (Auto-COVID-VACC): Protocol for Multicenter Prospective Noninterventional Study. JMIR Research Protocols. 14. e60675–e60675.

Prattes, Juergen, Florian Amerstorfer, Tobias Niedrist, et al.. (2024). Soluble Urokinase Plasminogen Activator Receptor (SuPAR) Analysis for Diagnosis of Periprosthetic Joint Infection. Antibiotics. 13(2). 179–179.

Egger, Matthias, et al.. (2024). Comparative Analysis of the Clarus Aspergillus Galactomannan Enzyme Immunoassay Prototype for the Diagnosis of Invasive Pulmonary Aspergillosis in Bronchoalveolar Lavage Fluid. Mycopathologia. 189(4). 67–67. 1 indexed citations

Egger, Matthias, Karl Dichtl, Juergen Prattes, et al.. (2024). Performance of the clarus Aspergillus galactomannan enzyme immunoassay prototype for the diagnosis of invasive pulmonary aspergillosis in serum. Mycoses. 67(6). e13756–e13756. 3 indexed citations

Gago, Sara, Matteo Bassetti, Daniele Roberto Giacobbe, et al.. (2024). Mycobiome analyses of critically ill COVID-19 patients. Microbiology Spectrum. 13(2). e0411023–e0411023. 1 indexed citations

Salmanton‐García, Jon, Martin Hoenigl, Helmut J.F. Salzer, et al.. (2023). The Austrian landscape of diagnostic capacity and access to treatment for invasive fungal infections. Mycoses. 66(12). 1056–1063. 7 indexed citations

Koehler, Philipp, et al.. (2023). Which trial do we need? Combination treatment of Pneumocystis jirovecii pneumonia in non-HIV infected patients. Clinical Microbiology and Infection. 29(10). 1225–1228. 5 indexed citations

Jenks, Jeffrey D., Juergen Prattes, Sebastian Wurster, et al.. (2023). Social determinants of health as drivers of fungal disease. EClinicalMedicine. 66. 102325–102325. 30 indexed citations

Aerts, Robina, et al.. (2023). Point-of-care testing for viral-associated pulmonary aspergillosis. Expert Review of Molecular Diagnostics. 24(3). 231–243. 13 indexed citations

10.

Mead, Matthew E., Patrícia Alves de Castro, Jacob L. Steenwyk, et al.. (2023). COVID-19-Associated Pulmonary Aspergillosis Isolates Are Genomically Diverse but Similar to Each Other in Their Responses to Infection-Relevant Stresses. Microbiology Spectrum. 11(2). e0512822–e0512822. 3 indexed citations

11.

Reisinger, Alexander C., Stefan Hatzl, Juergen Prattes, et al.. (2023). Soluble urokinase plasminogen activator receptor (suPAR) in bronchoalveolar fluid and blood in critically ill patients—a prospective cohort study. Infection. 52(1). 249–252. 1 indexed citations

12.

Egger, Matthias, Angela Horvath, Florian Prüller, et al.. (2023). Fungal translocation measured by serum 1,3‐ß‐D‐glucan correlates with severity and outcome of liver cirrhosis—A pilot study. Liver International. 43(9). 1975–1983. 10 indexed citations

13.

Mileder, Lukas P., et al.. (2020). Simulation-based training and assessment of mobile pre-hospital SARS-CoV-2 diagnostic teams in Styria, Austria. Medicine. 99(29). e21081–e21081. 6 indexed citations

14.

Mercier, Toine, Maud Gits‐Muselli, Samia Hamane, et al.. (2020). Variable Correlation between Bronchoalveolar Lavage Fluid Fungal Load and Serum-(1,3)-β-d-Glucan in Patients with Pneumocystosis—A Multicenter ECMM Excellence Center Study. Journal of Fungi. 6(4). 327–327. 14 indexed citations

15.

Jenks, Jeffrey D., Stephen A. Rawlings, Carolina García‐Vidal, et al.. (2019). Immune Parameters for Diagnosis and Treatment Monitoring in Invasive Mold Infection. Journal of Fungi. 5(4). 116–116. 13 indexed citations

16.

Hoenigl, Martin, Thomas Orasch, Klaus Faserl, et al.. (2018). Triacetylfusarinine C: A urine biomarker for diagnosis of invasive aspergillosis. Journal of Infection. 78(2). 150–157. 39 indexed citations

17.

Theiler‐Schwetz, Verena, Christian Trummer, Claudia Friedl, et al.. (2017). Visceral leishmaniasis in a patient with diabetes mellitus type 2 and discrete bicytopenia. Clinical Case Reports. 6(1). 78–81. 5 indexed citations

18.

Prattes, Juergen, Sven Heldt, Susanne Eigl, & Martin Hoenigl. (2016). Point of Care Testing for the Diagnosis of Fungal Infections: Are We There Yet?. Current Fungal Infection Reports. 10(2). 43–50. 36 indexed citations

19.

Prattes, Juergen, Michaela Lackner, Susanne Eigl, et al.. (2015). Diagnostic accuracy of the Aspergillus ‐specific bronchoalveolar lavage lateral‐flow assay in haematological malignancy patients. Mycoses. 58(8). 461–469. 45 indexed citations

20.

Prattes, Juergen, Holger Flick, Florian Prüller, et al.. (2014). Novel Tests for Diagnosis of Invasive Aspergillosis in Patients with Underlying Respiratory Diseases. American Journal of Respiratory and Critical Care Medicine. 190(8). 922–929. 102 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact